BDO Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$924K Buy
6,855
+2,779
+68% +$408K 0.11% 140
2023
Q1
$650K Hold
4,076
0.08% 151
2022
Q4
$659K Sell
4,076
-229
-5% -$35.1K 0.08% 156
2022
Q3
$578K Sell
4,305
-125
-3% -$17.9K 0.08% 158
2022
Q2
$678K Sell
4,430
-77
-2% -$11.8K 0.08% 148
2022
Q1
$731K Sell
4,507
-58
-1% -$8.43K 0.08% 154
2021
Q4
$618K Sell
4,565
-2,181
-32% -$258K 0.07% 164
2021
Q3
$728K Buy
6,746
+1,563
+30% +$179K 0.08% 155
2021
Q2
$584K Buy
5,183
+110
+2% +$12.4K 0.06% 172
2021
Q1
$549K Buy
5,073
+855
+20% +$91.5K 0.06% 169
2020
Q4
$452K Buy
4,218
+425
+11% +$40.8K 0.06% 151
2020
Q3
$332K Sell
3,793
-193
-5% -$18.2K 0.05% 168
2020
Q2
$391K Sell
3,986
-172
-4% -$15.1K 0.07% 143
2020
Q1
$317K Buy
4,158
+2,240
+117% +$191K 0.06% 152
2019
Q4
$170K Buy
1,918
+307
+19% +$25.5K 0.04% 204
2019
Q3
$122K Buy
1,611
+239
+17% +$16.4K 0.03% 240
2019
Q2
$100K Hold
1,372
0.03% 247
2019
Q1
$111K Sell
1,372
-775
-36% -$63.4K 0.03% 216
2018
Q4
$198K Buy
2,147
+553
+35% +$48.6K 0.07% 148
2018
Q3
$151K Sell
1,594
-14
-0.9% -$1.33K 0.05% 179
2018
Q2
$149K Buy
1,608
+106
+7% +$10.4K 0.05% 178
2018
Q1
$142K Buy
1,502
+162
+12% +$17.8K 0.05% 152
2017
Q4
$130K Buy
1,340
+21
+2% +$1.98K 0.06% 137
2017
Q3
$117K Sell
1,319
-265
-17% -$20.2K 0.06% 131
2017
Q2
$115K Buy
+1,584
New +$106K 0.05% 159

Other funds holding ABBV

BDO Wealth Advisors's ABBV Position: Q2 2023 in Review

BDO Wealth Advisors increased its AbbVie (ABBV) stake by 68% in Q2 2023, buying an estimated $408K and bringing the position to 6,855 shares worth $924K. The position accounts for 0.11% of the portfolio, ranked #140.

BDO Wealth Advisors first reported a position in ABBV in Q2 2017 and has held it in 25 quarters since. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • BDO Wealth Advisors held 6,855 shares of AbbVie worth $924K as of Q2 2023.
  • BDO Wealth Advisors bought 2,779 AbbVie shares in Q2 2023, an estimated $408K.
  • AbbVie made up 0.11% of BDO Wealth Advisors's portfolio in Q2 2023, its #140 holding.
  • BDO Wealth Advisors first reported a position in AbbVie in Q2 2017 and has held it in 25 quarters since.
  • 3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on BDO Wealth Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.